Medical Research
(H12)
IRS Verified
DX Registered
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$6.5M
Total Revenue
$23.2M
Total Expenses
N/A
Net Assets
9
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$593K
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $6.5M | $23.2M | N/A | — | 9 |
| 2022 | $52.5M | $8.9M | N/A | — | 8 |
| 2021 | $4.0M | $5.8M | N/A | — | 6 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.